Balancing Release and Permeation Rates in Cyclosporine Amorphous Solid Dispersions
- 4 September 2026
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (10) , 5033-5043
Abstract
The solubility advantage of an amorphous drug can be realized only when it releases at a sufficiently rapid rate from its amorphous solid dispersion (ASD). Herein, we evaluated the impact of a plasticizer, glyceryl tributyrate (GTB), on the release of a poorly soluble drug with a high glass transition temperature (Tg). Cyclosporine has a Tg of 124 °C and was formulated as an ASD with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Binary and ternary ASDs were prepared using solvent evaporation, their Tgs were measured using differential scanning calorimetry, and surface area normalized release rates were determined. The drug-rich phase formed above the amorphous solubility was characterized for composition and size. Drug flux following release from the ASD was measured across Caco-2 cell monolayers. Cyclosporine released at a substantially faster rate from ternary ASDs containing GTB as compared to the corresponding binary ASD. This improvement was attributed to a decrease in Tg upon plasticization due to GTB increasing molecular mobility. Addition of GTB, however, reduced the amorphous solubility of cyclosporine resulting in a decrease in the transport rate across the Caco-2 cell monolayer. These observations may have implications for drug absorption. Ultimately, it is expected that the in vivo performance of these ternary ASDs would be determined by the interplay between the enhanced release rate and the decreased permeation rate of the drug.Keywords
Funding Information
- AstraZeneca
This publication has 61 references indexed in Scilit:
- Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology PlatformClinical Pharmacology in Drug Development, 2024
- Release Enhancement by Plasticizer Inclusion for Amorphous Solid Dispersions Containing High Tg DrugsPharmaceutical Research, 2023
- Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and CopovidonePharmaceutical Research, 2022
- Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer InteractionPharmaceutical Research, 2016
- What Is the Mechanism Behind Increased Permeation Rate of a Poorly Soluble Drug from Aqueous Dispersions of an Amorphous Solid Dispersion?Journal of Pharmaceutical Sciences, 2014
- The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco‐2 cell lineJournal of Pharmaceutical Sciences, 2012
- The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation DevelopmentJournal of Pharmaceutical Sciences, 2010
- Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification SystemPharmaceutical Research, 2005
- Water Vapor Absorption into Amorphous Hydrophobic Drug/Poly(vinylpyrrolidone) DispersionsJournal of Pharmaceutical Sciences, 2002
- Diffusion and localized swelling resistances in glassy polymersPolymer Engineering & Science, 1982